Porträt Melanie Waldenberger

Head of "Complex Diseases", Senior Scientist

Dr. Melanie Waldenberger

“I aim to understand the involvement of DNA methylation and other molecular layers in cardiometabolic traits and the impact of lifestyle factors on the human methylome.”

Academic career and research areas

Dr. Melanie Waldenberger holds both a Diploma in Biology and a Master’s in Public Health. In 2009, she received her doctorate in natural sciences from the Technical University of Munich. She then worked as a postdoc at the Research Unit Molecular Epidemiology, Institute for Epidemiology, Helmholtz Zentrum München. Since 2012, she has headed her own research group, "Complex Diseases". 


The research of Melanie focuses on the molecular analysis of complex diseases – such as cardiovascular and metabolic conditions – and their intermediate phenotypes. Melanie has particular experience in the conduct of high-throughput genotyping and genome-wide methylation projects. The group uses epidemiological methods to study the complex interplay between molecular mechanisms and environmental factors in the context of the onset and progression of disease. 

Fields of Work and Expertise

Molecular Epidemiology DNA methylation Genetics OMICs data

Professional Background

Since 2012

Head of Research Group "Complex Diseases"

2009

PhD in Natural Sciences (Dr. rerum naturae), Technical University of Munich and Center of Natural Sciences Weihenstephan

2008

Postgraduate Master of Public Health and Epidemiology, Ludwig-Maximilians-University Munich

2002

Master of Science in Biology, Technical University Munich

Media Coverage

Networks and Affiliations

Logo DZHK - Deztsches Zentrum für Herz-Kreislauf-Forschung

DZHK - German Center for Cardiovascular Research

Read more
Logo DZGP Deutsches Zentrum für Psychische Gesundheit

DZPG - German Center for Mental Health

Read more
Logo GLOHRA - German Alliance for Global Health

GLOHRA - German Alliance for Global Health Research

Read more

Looking for a new challenge?

Join our team.